SX29
Product Specifications
Target
Glucosidase, glycosidase
Related Pathways
Metabolism
Bioactivity
SX29 is a non-competitive α-glucosidase inhibitor with oral activity, exhibiting an IC50 of 2.12 μM. It possesses hypoglycemic properties; oral administration of SX29 reduces blood glucose levels and enhances glucose tolerance in diabetic mice.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1213496-01 0.02 mg (E-Coli)
Recombinant Clostridium kluyveri 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1213496-02 0.1 mg (E-Coli)
Recombinant Clostridium kluyveri 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1213496-03 0.02 mg (Yeast)
Recombinant Clostridium kluyveri 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1213496-04 0.1 mg (Yeast)
Recombinant Clostridium kluyveri 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1213496-05 0.02 mg (Baculovirus)
Recombinant Clostridium kluyveri 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1213496-06 0.02 mg (Mammalian-Cell)
Recombinant Clostridium kluyveri 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details